MassChallenge

CNS Therapy, they contribute to human well-being through mind-body therapy and the research, design, education, and sale of devices that alleviate chronic disease, restore health, and extend useful life. They are a spin off from the University of North Carolina (UNC). Their base technology is a patent pending approach to chronic pain which combines operant behavioral therapy with a proprietary device which enhances learning and resets the autonomic nervous system - called SET - Systolic Extinction Training. They are dedicated to providing long lasting pain relief to patients. Their unique combination of psychological training and electrostimulation helps chronic pain patients to starkly reduce or even eliminate their pain and allow them to return to their daily lives.

HeroSupport is a medical device manufacturing company based in Veyrier, Geneva, established in 2019. The company specializes in creating personalized solutions that transform imaging and treatment tables into medical immobilization devices designed to enhance patient comfort during clinical procedures. By providing tailored support, these devices allow patients to receive prone breast radiotherapy without the need to adapt to the standard table setup. This innovation not only improves patient comfort but also aims to enhance the effectiveness and cost efficiency of cancer treatment for healthcare providers.

Aseptuva is an early-stage MedTech startup located in Technopark Winterthur, dedicated to addressing Healthcare-Associated Infections (HAI) that arise from catheter use in healthcare facilities. Catheters, essential for delivering medications, are often contaminated with pathogens, leading to severe complications such as pneumonia and bloodstream infections, which result in significant mortality and substantial healthcare costs. To combat this issue, Aseptuva is developing innovative medical devices designed for in-situ disinfection of various catheters, aiming to prevent infections before they occur. The company’s technology offers a robust automated system that assists medical staff, ultimately helping hospitals reduce the incidence of infections and save lives. Aseptuva aspires to establish a new standard in critical care, positively influencing millions of patients worldwide.

Skygenic is a cloud-based software platform designed to facilitate the storage and analysis of genomic data, thereby enhancing the research capabilities of scientists. Developed in collaboration with experts from Harvard Medical School and Boston Children's Hospital, the platform aims to simplify the data analysis process for non-programming scientists, enabling them to independently analyze and interpret biological data. By addressing the challenges faced in early-stage and translational research, Skygenic effectively reduces the reliance on bioinformaticians, allowing research to progress more efficiently and economically. This innovation supports academic institutions, hospitals, biotechnology, and pharmaceutical organizations by streamlining workflows and enabling researchers to focus on critical aspects of their work, ultimately accelerating scientific discovery.

Ember Sleep is a company focused on improving sleep quality through its innovative sleep apnea treatment platform. The platform features medical devices designed to be more comfortable, effective, and non-invasive for the treatment of sleep apnea. By providing a novel approach to open the airway, Ember Sleep aims to enhance the well-being of patients, enabling them to feel more rested while assisting healthcare professionals in delivering better health outcomes.

Pulse Charter Connect specializes in streamlining organ transportation logistics. It operates a digital platform that automates and optimizes both air and ground transportation processes, replacing manual methods. This enables medical professionals to concentrate on their critical tasks, saving time, reducing costs, and enhancing the likelihood of successful organ transplants.

Symphony Biosciences is focused on developing innovative cancer therapies aimed at improving treatments for solid tumors, particularly targeting triple-negative breast cancer. This type of cancer currently has limited effective treatment options, primarily relying on toxic chemotherapies that often fail to provide significant survival benefits. By utilizing biomaterials in its research, Symphony Biosciences aims to enhance the immune response against these challenging cancers, ultimately providing healthcare professionals with better tools to treat patients. The company's mission is to improve patient access to effective cancer treatments and address the critical needs within oncology.

KardioStatus is a healthcare technology company that converts biometric data into personalized clinical treatments. Its platform, developed by leading physicians and engineers, creates unique biometric profiles for patients and provides tailored therapeutic recommendations, helping healthcare providers enhance patient outcomes, lower costs, and simplify decision-making processes.

Narval is a biotechnology company specializing in the development of synthetic antibody mimetic proteins (AMPs). These AMPs are significantly smaller than conventional antibodies, yet retain their biological functionality. They offer several advantages, including the ability to penetrate tissue barriers, generate limited immune reactions, target small and hard-to-reach antigens, and withstand heat. Narval's technology enables the creation of novel first-in-class immunotherapeutic drugs for diseases previously challenging to treat with monoclonal antibodies, such as respiratory, eye, and autoimmune conditions. The company leverages machine learning and artificial intelligence to optimize its drug development capabilities.

Pills2Me is a pharmacy delivery service focused on improving healthcare by removing barriers to medication access and adherence. The company offers a platform that facilitates the pickup of prescriptions from any pharmacy and delivers them directly to individuals. In addition to prescription deliveries, users can shop for over-the-counter pharmacy items through the application. This service is particularly beneficial for elderly and immunocompromised individuals, allowing them to maintain social distancing while ensuring they have access to essential medications.

Trove Health offers a platform designed to enhance access to patient data for patients, healthcare providers, and life sciences organizations. The company's primary focus is on clinical trial recruitment, where it aims to build a diverse and engaged database of consented participants. By efficiently identifying and recruiting patients who meet specific enrollment criteria across various geographies and therapeutic areas, Trove Health enables researchers to advance medical cures and therapies. Additionally, the platform empowers patients by allowing them to control and potentially monetize their health information while receiving tailored treatments.

Benten Technologies is a social impact company dedicated to democratizing healthcare. The organization has secured approximately $9 million in non-dilutive funding to develop a pipeline of digital therapeutics aimed at making healthcare services more accessible. In addition to its healthcare initiatives, Benten Technologies also provides technology consulting services, which encompass application development, management consulting, quality assurance, and research and development. By leveraging proven system integration methodologies and expertise, the company enables organizations to deliver effective, value-driven business solutions.

Mobile app for tracking, understanding, and improving mental health. We're working on making mental healthcare more quantitative. If that sounds interesting to you, get in touch!

Stellate Therapeutics is a private biotechnology company specializing in the development of small molecules derived from human gut bacteria to create personalized therapies for neurological diseases. The company focuses on addressing age-related neurological conditions, particularly through its research on the gut-brain axis. Stellate has developed a portfolio of drug candidates, including AMA-101, which aims to be a first-in-class therapy for Parkinson's disease. Through its microbiome-derived medicine platform, Stellate Therapeutics is engaged in comprehensive research and has established capabilities in discovery, screening, production, and diagnostic development, striving to provide effective treatments for neurological disorders.

Flagler Health is a developer of clinical decision support software that transforms clinics into virtually vertical health systems. The company offers a platform that leverages patient data and clinical guidelines to assist physicians in identifying potentially beneficial procedures that may have been overlooked. By utilizing advanced AI technologies, Flagler Health recommends optimal treatment strategies based on individual patient data, enabling healthcare providers to deliver more comprehensive care. This approach aims to improve patient outcomes and enhance the overall efficiency of healthcare delivery.

Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.

Speratum is a biopharmaceutical company focused on microRNA-directed oncology therapies. The Company was founded in 2014 by Christian Marín-Müller, Ph.D. and is dedicated to the development of a patented treatment for pancreatic cancer based on the combination of tumor suppressive microRNA molecules and nanoparticle-based drug delivery technologies. The Company is currently entering the final stage of preclinical trials for the pancreatic cancer therapy, while simultaneously expanding the patent’s coverage to incorporate other types of cancer and non-cancer indications and illnesses and expanding its intellectual property (IP) portfolio with complementary technologies in the fields of nanotechnology, medical devices and veterinary medicine.

Helthy is a technology company that offers a browser extension, integrating with major online grocery retailers, to provide real-time food assessments and personalized recommendations for individuals with diabetes or prediabetes. The platform helps users make healthier choices during online grocery shopping by highlighting suitable alternatives and tracking dietary preferences, thereby supporting better blood sugar level management.

Birth By Us empowers mothers and birth attendants to customize their own birthing experience while providing caregivers with the insights and data needed to best assist their birth.

Nanoplex is a healthcare and life sciences company.

Blue Halo BioMedical, LLC, founded in 2019 and based in Winter Park, Florida, specializes in developing innovative catheter surgical devices tailored for urologic patients. The company aims to transform the longstanding urologic catheter market with its fully internal male urinary catheter designed to effectively drain the bladder. This proprietary device addresses a key issue in urologic care by reducing the risk of catheter-associated urinary tract infections (CAUTI) and significantly improving the quality of life for patients. By allowing individuals to void at will, Blue Halo BioMedical’s catheters enable users to engage in normal activities without the limitations imposed by traditional catheter systems.

Code 1 Medical Devices provides medical solutions to prevent the aspiration of stomach contents into the lungs.

Lavaa is a healthcare technology company focused on enhancing value-based primary care and accountable care solutions. Its flagship product, HealthLinksAI, serves as an AI-powered operating system designed for care teams, integrating effectively with electronic medical records, billing systems, and clinical workflows. This platform converts raw healthcare data into actionable insights tailored to various roles, enabling care coordinators, nurses, and billing teams to manage patient risk proactively and improve health outcomes while identifying new revenue opportunities. Lavaa's customizable technology is built on physician-certified logic, allowing for rapid deployment and measurable impact. The company also offers support for external vendors through its clinical API and Intelligence Studio, facilitating connections in remote patient monitoring, chronic care management, clinical trials, and behavioral health. With backing from industry leaders and venture capital, Lavaa is making significant strides in Medicare Advantage, Accountable Care Organizations, and population health initiatives across the United States.

From Women For Women is a new unique breast pad developed by B-gin A-ge.

KT Innovations is a provider of medical devices that aims to prevent costly & life threatening urinary tract and skin infections.

Lighthanded Enterprises specializes in the development of innovative medical technology aimed at diagnosing middle ear effusions, particularly otitis media with effusion (OME), which is common in children. The company has created a laser otoscope that enhances diagnostic accuracy by providing an additional illumination source. This technology enables healthcare professionals to achieve up to ninety percent accuracy in identifying OME during examinations. By improving the detection of chronic middle ear effusions, Lighthanded Enterprises empowers doctors to make more informed decisions regarding patient care and treatment referrals, ultimately addressing a significant issue that can impair children's hearing for prolonged periods.

SafeGuard Surgical is a medical device company focused on improving surgical outcomes and patient safety. It develops innovative, resorbable products designed to enhance colonic anastomotic healing and stability during advanced surgical procedures. These include a resorbable intraluminal stent graft and an extraluminal resorbable graft, along with anvil cap extension arms. By employing these products, SafeGuard aims to reduce surgical complications, lower healthcare costs, and minimize patient recovery time, ultimately preventing mortality and morbidity associated with surgery.

DocNexus is transforming the healthcare landscape by leveraging AI-powered knowledge graphs to enhance access to critical information. The company's platform provides a comprehensive database for key opinion leader (KOL) searches, advanced publication searches, and news aggregation, allowing medical affairs organizations to efficiently find evidence and stay updated on KOLs' digital presence. By delivering insights from millions of scientific publications, clinical trials, and news articles in seconds, DocNexus streamlines the process of connecting healthcare professionals across the ecosystem. This innovative approach enables clients to strengthen their medical affairs strategies and improve scientific exchange.

Electronrx specializes in personalized digital medicine, focusing on innovative solutions for chronic disease management and hospital patient care. The company has developed a predictive healthcare and diagnostics platform that monitors cardiovascular health remotely. This platform utilizes advanced technologies, including biomedical engineering, data science, and machine learning, to sense the physiological environment and deliver tailored therapeutic interventions. By enabling clinical professionals to provide targeted treatments through short waveforms of current and voltage, Electronrx empowers patients to self-monitor their health and effectively manage conditions such as period pain during treatment.

Perfusion Medical has an IV solution for tissue perfusion restoration developed at VCU of medicine and is being commercialized. They have the potential to be game changers in the treatment of severe blood loss. PEG-20k IV solution's main mechanism of action in treating severe hypovolemic shock is to increase tissue perfusion, allowing for the rapid transfer of oxygen into oxygen-depleted tissues and organs.

XN Health is a medical device company based in Texas, founded in 2021. The company specializes in developing healthcare devices aimed at improving the process of mechanical ventilation. Its innovative technology focuses on phrenic nerve stimulation, which induces diaphragm contractions during ventilation. This approach helps protect against diaphragm dysfunction in patients who are mechanically ventilated, ultimately enabling them to wean off the ventilator more quickly and safely.

Astra Wellbeing is a B2B software company that focuses on employee recognition and wellness. It provides a platform that sends tailored, positive reinforcement messages via SMS to frontline healthcare employees, aiming to reduce burnout, increase engagement, and enhance overall employee welfare. The company caters to both corporate and small business clients, offering solutions to help manage employee appreciation and retention.

Bairitone Health, founded in 2022 and headquartered in Houston, Texas, develops innovative solutions for individuals with untreated obstructive sleep apnea. The company specializes in remote passive sensing technology that employs vibration sensors placed on the face during sleep to gather acoustic data from the upper airway. This data is then analyzed using sonar beam-forming algorithms and artificial intelligence, allowing for precise identification of sound locations associated with structural collapses in the upper airway during apnea episodes. By providing detailed insights, Bairitone Health enables healthcare professionals to formulate informed treatment plans for sleep apnea, addressing a critical health issue for many individuals.

Aevice Health specializes in non-invasive wearable technology aimed at monitoring respiratory health in real-time. The company develops devices specifically for asthmatic patients, which track and record vital historical data related to respiratory symptoms and medication usage. This technology facilitates the early detection of cardiopulmonary issues, enabling clinicians to monitor patient responses to treatment effectively. By providing critical health insights from the comfort of home, Aevice Health enhances patient care and allows for quicker, more targeted medical interventions.

Dream Team Baby is a leading infant and toddler sleep consulting business, operating for over a decade. Backed by a board of medical advisors, the company offers holistic sleep solutions, believing every child can learn to love sleep. Services include comprehensive sleep assessments, custom sleep plans, and intensive coaching, along with parent support and child behavior advice. Dream Team Baby works with families nationwide and has been featured on national media outlets like the Today Show.

Astron Medtech is a medical technology company focused on improving patient outcomes in tendon repair. The company develops disposable minimally invasive surgical devices that significantly reduce recovery time from six months to four months. By utilizing less invasive and sustainable surgical techniques, Astron Medtech aims to enhance the efficiency of surgical services while providing better options for patients undergoing tendon repair procedures.

DetoXyFi focuses on developing sustainable water filtration devices aimed at providing access to clean drinking water globally. The company leverages xylem tissue from plants to create highly effective filters that are both biodegradable and rapidly deployable. These filters are designed to remove a range of chemical and microbial impurities, effectively protecting users from organic and inorganic toxins as well as waterborne diseases. By utilizing waste wood in their production process, DetoXyFi emphasizes environmental sustainability while addressing critical public health needs.

HME Square is a digital healthcare company focused on developing medical diagnostics and devices that utilize innovative technology for health monitoring. The firm specializes in creating non-invasive glucose monitoring systems designed to measure health data accurately and continuously without the need for blood sampling or needles. By integrating photoacoustics, MEMS device technology, and deep learning into a cohesive digital data platform, HME Square aims to prevent chronic diseases and empower individuals to manage their glucose levels effectively, thereby promoting healthier lifestyles.

Corveus Medical is focused on creating innovative solutions to prevent heart failure through the development of a neuromodulation device. This catheter-based technology aims to safely and effectively access nerve tissue, enabling nerve ablation for improved treatment outcomes. By employing minimally invasive methods, Corveus Medical seeks to alleviate both the clinical and economic burdens associated with heart failure, marking a significant advancement in the field of cardiac care. The company is committed to delivering consistent results and enhancing patient quality of life through its pioneering approach to heart failure treatment.

Elythea is a technology company that develops a medical platform for obstetricians. This platform uses machine learning and deep learning algorithms to predict the risk of pregnancy complications, such as postpartum hemorrhage, cesarean section, and eclampsia, as early as the first trimester. It leverages clinical history and demographic information available at the point of care, enabling doctors to prepare for potential high-risk cases months in advance. Elythea's proprietary models have shown significantly higher sensitivity in predicting hemorrhage risk compared to current gold standard assessments, potentially reducing mortality and healthcare costs by over 90%.

Auspex Diagnostics is an AI startup focused on enhancing cancer care through advanced diagnostic services. It utilizes machine learning algorithms to analyze the genomic information from patients' tumor samples. This analysis helps in accurately assessing the risk of cancer recurrence and the efficacy of various treatments. By providing valuable insights, Auspex Diagnostics enables oncologists and patients to make informed, data-driven decisions regarding personalized treatment plans, ultimately aiming to improve the overall quality of cancer care.

unique approach targets end-to-end health, nutrition, fitness and wellness so that no chronic health conditions, Using machine learning to study behavior change. innovative tech is enhanced by human connection through 1:1 coaching.

CranioSense is bringing intracranial hypertension into the light by simplifying the diagnostic process across the clinical spectrum.

Dart Biosciences works in the healthcare industry. It creates tailored gene therapies for a variety of uncommon and prevalent disorders.

ABBY is a new Personal EV for adults with reduced mobility, positioned as a long-overdue expansion play for the broken $9B wheelchair cartel

QuitSure is a technology company that operates a smoking cessation program via a mobile application. The 6-day program employs behavioral science and psychological tools to help smokers quit quickly, permanently, and without cravings. It offers a combination of reading materials, videos, and simple exercises to facilitate the quitting process. Additionally, the platform provides personal consultations to support users throughout their journey.

Azooka is a biotechnology company focused on manufacturing proprietary fluorophores and molecular biology products for life science research and molecular diagnostics. The company produces a range of fluorescent dyes and tags for applications involving DNA, RNA, chromosomes, and live cells, as well as molecular-grade sample collection and transport mediums. Azooka aims to provide secure and sustainable biotech consumables at affordable prices, making these essential tools accessible to researchers worldwide. Recently, the company was recognized as the "Best Women-Led Enterprise," highlighting its commitment to innovation and leadership in the biotech sector.

MZP Tech is a company focused on point-of-care coagulation analysis, aiming to improve healthcare delivery through innovative diagnostic methodologies. They develop medical devices capable of rapidly analyzing blood samples, utilizing a disposable micro-machined chip and a portable embedded sensing system. This technology allows for the analysis of a single drop of blood within minutes, measuring blood viscosity. By doing so, MZP Tech enables healthcare professionals to conduct early-stage screenings for various conditions, including cardiovascular diseases, blood-clotting disorders, and hyperviscosity-related issues. Their advancements in hemostasis contribute to better management of bleeding and thrombotic risks, enhancing patient care.

Anviron is a company focused on developing advanced therapies for late-stage cancers. It employs a team of scientists, doctors, and clinicians who work collaboratively to address the challenges posed by difficult-to-treat cancers. By leveraging cutting-edge scientific research, Anviron aims to create innovative therapies that meet the unmet medical needs in oncology. The company's efforts are directed towards improving patient outcomes and transforming the landscape of cancer care.

Developer of a digital healthcare platform designed to predict heart issues based on electrocardiogram readings. The company's platform leverages artificial intelligence that analyzes ECG and builds a personal profile of the patient that is then used to detect, predict, and alert of significant cardiac events and any abnormal or declining functions, enabling doctors to speed up the proactive cardiovascular diagnostics process.

Women aged 20-45 cannot get screened for breast cancer because existing solutions are unreliable. However, 81% want to. At The Blue Box, we have built a pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine with a sensitivity of 83%. In 2024, we’ll launch into the market, bringing The Blue Box to private gynecology clinics with a Diagnostics-as-a-Service subscription model, and a pay-per-test revenue stream that we’ll share with doctors.

Tiny Docs, founded in 2015, provides a learning platform aimed at educating children and families about health in an accessible and engaging manner. Recognizing the importance of clear communication in healthcare, the company creates resources that simplify complex health issues and surgical procedures through short cartoons. This approach allows children to understand various health topics and empowers families to make informed decisions regarding their health. By bridging the communication gap between healthcare providers, children, and their families, Tiny Docs focuses on improving health outcomes and fostering a positive impact on children's well-being.

Flourish Science is a digital mental health organization that was founded in order to deliver personalized and community-oriented well-being knowledge and practices based on social psychology, positive psychology, and behavioral science.

Taurus Vascular is a medical device company dedicated to enhancing long-term outcomes for patients with aortic aneurysms. The company is focused on developing innovative technology aimed at transforming the standard of care for these patients. Its novel medical device is designed to eliminate the adverse effects of endoleaks and promote accelerated shrinkage of aneurysm sacs following endovascular aortic aneurysm repair (EVAR). By addressing these critical issues, Taurus Vascular aims to improve patient outcomes within the healthcare industry.

Hybridwerx enables clinicians to enter notes fast and focus on assisting patients.

IC Innovations develops disruptive technology for respiration measurement and analysis. We are focused on lowering the barriers to access to advanced respiratory assessment, in fields such as sports and healthcare.

TrainFES is a digital neuro-rehabilitation platform designed to assist individuals with paralysis in their recovery process. By offering a combination of rehabilitation orthopedic devices and a mobile application, TrainFES enables users to engage in effective therapies from the comfort of their own homes. This approach not only reduces the costs associated with traditional rehabilitation methods but also aims to deliver improved outcomes for patients. The platform specifically targets individuals with spinal cord injuries and those recovering from cerebrovascular accidents, providing tools that facilitate monitoring and enhance the quality of life for users facing physical disabilities.

Arnav Biotech is a biotechnology company that operates as a Contract Development and Manufacturing Organization (CDMO), specializing in mRNA technology. It offers services for the design, development, and manufacturing of custom and cataloged mRNA products, supporting research, therapeutics, and vaccines. By providing these services, Arnav Biotech enables researchers to concentrate on their specific areas of interest, thereby democratizing access to mRNA-based life sciences.

Pharmesol is a clinical services platform focused on automating follow-up care for medications. It utilizes AI technology to streamline communication among pharmacy stakeholders, including patients, healthcare providers, and payers. By automating calls and messages, Pharmesol enhances engagement and support for both patients and doctors. The platform also emphasizes effective data management through recorded documentation, ensuring that personalized support is accessible 24/7. This approach aims to improve the overall experience of medication management and follow-up care.

ForesightCares is a technology company specializing in AI-driven healthcare solutions for the elderly. It aims to address the U.S.'s impending healthcare crisis, exacerbated by the growing aging population, often referred to as the "Silver Wave". The company develops AI technology to enhance elder care, focusing on routine motor function assessments. Its innovative system enables early detection and tracking of motor function deficits and fluctuations in older adults with conditions like Parkinson's, mild cognitive impairment, and balance issues. This technology benefits patients, caregivers, and healthcare providers by facilitating better health outcomes and improving quality of life.

They're more than a napkin company. Join our mission to end drug-facilitated sexual assault.KnoNap works to empower individuals and communities to create safer social settings, through education and products that bring attention to drug facilitated assault and crime.

Curespec is focused on developing a medical device known as Nephrospec, aimed at addressing the interconnected challenges of chronic kidney disease and hypertension. The device is designed to preserve kidney function, thereby delaying the need for dialysis and treating high blood pressure. By providing healthcare professionals with an innovative tool, Curespec seeks to reduce the suffering associated with kidney failure and hypertension, ultimately improving patient outcomes in these prevalent health conditions.

Developer of a healthcare technology designed to replace the traditional way of treating cancer treatment. The company aims to transform the traditional therapeutic into a next-generation therapy for cancer diseases by maximizing the drug potency with minimum toxicity, helping the healthcare sector to overcome systemic toxicity and exhibiting strong anti-tumor efficacy in various tumor models both as monotherapy and in combination with immune checkpoint inhibitors.

DoubleLock Healthcare specializes in developing innovative medical devices aimed at reducing healthcare-associated infections. Their primary product is a novel intravenous (IV) port and syringe system designed to enhance sterility and safety. This system, which does not require alcohol swabs or caps, is engineered to decrease healthcare costs, minimize medication errors, and improve overall patient safety in hospitals and other medical facilities.

True Concepts Medical Technologies is a medical device company dedicated to reducing financial waste in the healthcare system while enhancing patient outcomes. Founded in 2017 and based in Centerville, Ohio, the company develops innovative, cost-effective technologies that aim to save billions of dollars annually. Its flagship products are designed to improve the accuracy of medical procedures, including contaminant-free blood culture collection for sepsis diagnosis and treatment solutions for sudden cardiac arrest. By leveraging clinical experience and the product development expertise of Pixel and Timber, True Concepts Medical Technologies creates devices that minimize human error, ensure consistent clinical delivery, and ultimately reduce healthcare costs.

Intek Scientific develops multiplexed immunofluorescence imaging technology.This will empower clinicians and researchers to gain a deeper understanding of cancer and provide effective and customized therapeutic strategies to tackle even the most challenging cancers.

Qonect is a digital health platform that aims to make healthcare more affordable for individuals by providing immediate savings on medical and food expenses. It offers a free Digital Health Card, which grants users access to instant discounts on medical bills and medications. The platform also includes features such as medical emergency loans, electronic laboratory test reports, and appointment bookings. By focusing on financial assistance for medical emergencies, Qonect helps users manage their healthcare costs effectively, particularly for those who must pay out of pocket for their medical expenses.

Activate Health is a health management platform designed to enhance health tracking and management services. The platform offers a variety of features, including health audits, health sprints, coaching, and progress tracking. By leveraging these tools, Activate Health aims to help clients discover the untapped potential for improved health and well-being, ultimately promoting a better lifestyle.

EyeKnow specializes in an AI-driven monitoring system that enhances safety for children and seniors in home and care facility environments. Utilizing advanced computer vision technology, EyeKnow's solution provides continuous surveillance, detecting incidents such as falls or irregular activities, as well as monitoring interactions between caregivers and vulnerable individuals to identify potential abuse or negligence. The system integrates easily with existing security cameras and delivers real-time insights and alerts to stakeholders through a user-friendly mobile app and live dashboard. By combining AI with security camera footage, EyeKnow aims to protect vulnerable populations from violence and ensure peace of mind for families and caregivers.

InnoPsych is a mental health platform focused on addressing racial disparities in therapy and promoting emotional wellness within communities of color. The company provides a national directory of therapists of color, enabling individuals to easily find mental health professionals based on geographic location, therapy type, insurance, and personal background. InnoPsych also offers engaging programming designed to reshape conversations about mental health in BIPOC communities, along with wellness products that teach emotional wellness strategies. Through these initiatives, InnoPsych aims to transform the experience of therapy and make mental health resources more accessible and relevant to diverse populations.

Although the #1 indicator of therapeutic success is the patient-therapist fit, 1 in 2 adults quit therapy due to a lack of therapist fit. Getting this match wrong is costly for health insurers and therapists. Unmute focuses on increasing the match and long term success-rate for patients seeking therapy using machine learning algorithms.

Oculogenex is a biopharmaceutical company based in La Habra, California, established in 2020. The company specializes in developing gene therapies specifically aimed at treating retinal disorders. Its innovative approach involves ocular regenerative gene therapy that protects retinal pigment epithelial cells from oxidative stress-induced damage, which is a contributing factor to macular degeneration. By focusing on these therapies, Oculogenex aims to enhance the detection and treatment of various retinal disorders, ultimately supporting researchers in advancing novel drug solutions in this critical area of healthcare.

SOAP Health is a healthcare technology company based in Boca Raton, Florida, founded in 2019. It develops an artificial intelligence-powered platform designed to enhance physician productivity and improve patient outcomes. The platform captures and analyzes detailed patient data before medical visits and integrates with electronic health records to streamline clinical practice. By utilizing a conversational interface, it simplifies patient-reported data collection and risk assessment, producing nearly complete SOAP notes to assist physicians in clinical decision-making. This approach not only helps identify at-risk patients and facilitates early disease detection but also aims to increase patient engagement and satisfaction while reducing errors and liability exposure for healthcare providers.

CardMedic is a healthcare platform designed to enhance communication between healthcare staff and patients, addressing various barriers such as language differences, visual and hearing impairments, cognitive challenges, and literacy issues. The platform features a comprehensive library of digital flashcards that replicate clinical conversations on common healthcare topics. These flashcards are available in multiple formats, including multilingual options, sign language, easy-to-read text, and read-aloud capabilities. By facilitating clearer communication, CardMedic aims to improve the quality of care and reduce health inequalities, ensuring that patients can access essential healthcare information in a way that is understandable to them. The platform is accessible via smartphones, tablets, or desktops, making it a versatile tool for both patients and healthcare providers.

Welfie is a health platform designed to support K-12 schools in addressing contemporary health issues among children. It offers a comprehensive data platform that provides health data assessments and insights, enabling parents, healthcare providers, and community health leaders to make informed health decisions for children. Welfie emphasizes a whole-child approach by tracking various aspects of health, including social, emotional, and mental well-being, while also focusing on critical areas such as heart health, nutrition, fitness, and diabetes management. By equipping caregivers and educators with valuable resources, Welfie aims to enhance the overall health and wellness of students.

Canopie is a digital platform focused on addressing maternal depression and anxiety through customized, audio-based programs and automated coaching. By utilizing clinically validated therapeutic techniques, including adaptations of cognitive behavioral therapy and compassion-focused treatment, Canopie aims to prevent and manage maternal mental health disorders effectively. The platform collaborates with cities, payers, health systems, and healthcare providers to deliver accessible and affordable care for mothers, addressing significant barriers such as cost, scheduling, time constraints, and stigma associated with seeking help. Through its innovative approach, Canopie is dedicated to supporting pregnant women and new mothers in overcoming common mental health challenges.

HealthOpX specializes in developing software solutions for community-based organizations, health systems, and payers, aiming to enhance community member engagement and overall health outcomes. Their platform includes a predictive analytics tool that helps assess the risks associated with patient readmissions, emergency room visits, and morbidity. This technology supports healthcare practitioners by facilitating care coordination, improving medical adherence, and enhancing clinical experiences. Through its services, HealthOpX enables organizations to implement effective health programs and collaborate with government and health entities, ultimately providing accessible and cost-effective care to at-risk patients.

CBOH is a digital health platform that decentralizes control of health identity and data. It empowers users to control their digital health identity and share verifiable health statuses with whom they choose. It is on a mission to destigmatize health testing and eliminate the spread of transmissible infections.

Carium is a developer of an individualized healthcare platform that enhances the management of health and wellness journeys for users. The platform aims to deliver a personalized, actionable, and efficient care experience for both healthcare providers and their clients. By integrating augmented data from daily life, Carium equips care teams with the insights necessary to make informed clinical decisions. This approach not only fosters improved health outcomes but also helps reduce costs for healthcare providers and payers. As a result, Carium's platform contributes to better overall satisfaction for both care teams and the individuals they support.

Ferrum Health, Inc. is a health technology company based in Santa Clara, California, that develops an artificial intelligence platform aimed at preventing medical errors and improving patient outcomes. The platform analyzes patient data across health systems to identify gaps in care and deploys multiple computer vision algorithms to evaluate radiologic images for commonly overlooked pathologies, such as lung nodules and fractures. Additionally, a proprietary natural language processing algorithm correlates these findings with physician notes, enabling hospital quality officers to address potentially missed diagnoses. Founded in 2017, Ferrum Health focuses on ensuring quality assurance in critical healthcare decisions, thereby enhancing the overall patient care experience through the integration of AI-driven tools.

myBiometry is developing a platform to monitor/manage patients with chronic disease using biomarker data from proprietary sensors and ML to identify patients at risk of treatment failure. Our initial focus is asthma where treatment failure occurs over 46% of the time (11.5M US patients, $80 billion). We are developing a single use, disposable sensor and device to track a biomarker of inflammation in breath. The data determines changes in adherence, treatment response, and risk of attack.

Eupnoos is a health-tech company specializing in digital healthcare solutions for lung health and disease detection. The company has developed a smartphone-based application that utilizes the device's microphone and camera to perform clinical-grade lung function tests and symptom-guided assessments. This platform enables users to screen, measure, and track the progression of lung health issues. By providing device-agnostic, API-accessible automated testing and data interpretation, Eupnoos supports both clinical and consumer-grade respiratory monitoring devices. The company's services facilitate telehealth and remote patient monitoring, empowering individuals to gain insights into their lung health and access professional healthcare guidance.

Opeeka is a developer of AI-based mental health assessment software aimed at enhancing health and human services. The company's platform is designed for healthcare professionals, enabling them to transform assessment data into personalized treatment and care plans. By focusing on person-centered care, Opeeka's software assists mental and behavioral health care agencies in effectively planning and guiding interventions while tracking individual progress in recovery and resilience. Through its innovative approach, Opeeka aims to make a positive impact on the lives of children, adults, and families.

Delfina is a company that specializes in developing a personalized prenatal care system aimed at ensuring the safety of mothers and infants during pregnancy. By leveraging data and machine learning, Delfina's platform creates individualized pregnancy care plans that assess patient risk through various metrics. This approach not only enhances interventional workflows but also improves provider efficiency, facilitating early intervention in prenatal care. Delfina's commitment to data-driven insights is paving the way for clinical innovation, ultimately striving to deliver equitable and cost-effective healthcare solutions for expectant families.

Kintsugi is a developer of innovative voice biomarker software that identifies signs of depression and anxiety from short clips of free-form speech. The company's technology aims to enhance mental healthcare infrastructure by validating voice biomarkers, which assists medical practitioners in addressing mental health care gaps within risk-bearing health systems. Recognized for its advancements in artificial intelligence, Kintsugi has received multiple awards and was named one of Forbes' Top 50 AI companies to watch in 2022. By streamlining the detection of mental health issues, Kintsugi seeks to improve patient outcomes and ultimately save time and lives.

Together by Renee is a free app that uses generative AI to streamline and automate health tasks like ordering refills, booking appointments and completing forms in an easy user experience perfect for the 123 million aging Americans managing diabetes, obesity, hypertension, and more. Together measures vital signs like blood pressure via smartphone camera - with no devices or wearables required. Together requires no data entry, typing or integration to legacy systems, using just AI to automate patient-centric care coordination. 67% of Together’s first 15,000 users are over 55 years of age and Together enjoys NetPromoter score of +85.

juli is a digital healthcare startup founded in 2020, aimed at improving the lives of individuals with chronic conditions. The company develops an artificial intelligence-powered application that consolidates diverse healthcare data into a single platform. This application supports users dealing with various chronic health issues, such as asthma, migraines, depression, bipolar disorder, and chronic pain. By integrating data from smartphones, wearables, and self-reported information, juli enables users to self-track and manage their symptoms effectively. The founders, motivated by personal experiences with chronic conditions, leverage their expertise in big data to enhance healthcare outcomes and promote better understanding of health triggers and management strategies.

Patientory, Inc. is a healthcare technology company based in Atlanta, Georgia, established in 2015. It offers a health data management platform that enables individuals to securely store, manage, and share their health information. The platform empowers patients to take control of their medical records and chronic illness management while facilitating better communication and support between healthcare providers and patients. By integrating a blockchain-enabled network, Patientory streamlines access to health data, enhances care coordination, and provides insights into health outcomes. This approach aims to democratize health data ownership, reduce healthcare costs, and improve overall patient engagement and health management.

CardMedic is a healthcare platform designed to enhance communication between healthcare staff and patients, addressing various barriers such as language differences, visual and hearing impairments, cognitive challenges, and literacy issues. The platform features a comprehensive library of digital flashcards that replicate clinical conversations on common healthcare topics. These flashcards are available in multiple formats, including multilingual options, sign language, easy-to-read text, and read-aloud capabilities. By facilitating clearer communication, CardMedic aims to improve the quality of care and reduce health inequalities, ensuring that patients can access essential healthcare information in a way that is understandable to them. The platform is accessible via smartphones, tablets, or desktops, making it a versatile tool for both patients and healthcare providers.

Oculogenex is a biopharmaceutical company based in La Habra, California, established in 2020. The company specializes in developing gene therapies specifically aimed at treating retinal disorders. Its innovative approach involves ocular regenerative gene therapy that protects retinal pigment epithelial cells from oxidative stress-induced damage, which is a contributing factor to macular degeneration. By focusing on these therapies, Oculogenex aims to enhance the detection and treatment of various retinal disorders, ultimately supporting researchers in advancing novel drug solutions in this critical area of healthcare.

miniMarrow presents a new disruptive therapeutic approach for the in-situ production of blood components in leukemic patients to replace weekly and burdensome transfusions markedly increasing patient quality-of-life. miniMarrow is operating in stealth mode. miniMarrow was established in Renens, Vaud

Ostiio is focused on developing an innovative bone distraction system aimed at correcting skeletal deformities and deficiencies. The company has created a fully implantable device that is buried beneath the patient's skin, eliminating the need for external components. This advanced system features a magnetically driven distraction mechanism that can be expanded with precision and monitored remotely by physicians. This programmability provides surgeons with enhanced transparency and control during the treatment process, addressing a longstanding challenge in skeletal correction. Ostiio operates as a company under the Penn Center for Innovation, emphasizing its commitment to advancing medical technology in orthopedics.

Phimentum enables general dentists without specialized training to offer braces to their patients. This opens a high-profit revenue stream for dentists and lowering cost and geographic barriers for patients.

Opsin Biotherapeutics specializes in the development of gene therapies based on opsins, a class of light-sensitive proteins. The company's primary focus is to create a pipeline of treatments for pain management, aiming to provide effective alternatives to opioids.

Flourish Collective is a digital platform designed to support new and expecting families by enhancing access to maternal healthcare and wellness services. It features a marketplace that offers evidence-based products and vetted maternal wellness services, along with a funding mechanism that allows friends and family to contribute towards a positive birth and parenting experience. By providing resources for pregnancy, birth, and postpartum care, Flourish Collective aims to bridge gaps in maternal healthcare, making essential wellness services accessible to all mothers from pregnancy through motherhood.

Newton Tech specializes in mobile physiotherapy technology aimed at assisting stroke patients in their recovery. The company's flagship product, Mobi, provides individualized insights and real-time fall detection and prevention. By tracking patients' movements and recording their walking patterns, Mobi helps users develop a unique movement signature, which in turn offers personalized movement insights. Newton Tech's mission is to facilitate a healthier future for stroke survivors through innovative technology that enhances rehabilitation and promotes safety.

Wave Company is a diversified smart apparel firm focused on enhancing athletic performance and recovery through innovative technology. Its flagship product, WaveWear, utilizes patented compression and kinesiology features to aid in injury prevention and recovery for athletes. The company leverages its proprietary conductive silicone technology, Elecsil, to analyze human movement and enhance training experiences. In addition to developing advanced sportswear, Wave Company produces and sells core material technologies, including its bio-silicone technology, to various sectors such as sportswear, healthcare, and smart wear. This approach allows Wave Company to distribute finished products directly to consumers or license its material technologies to other brands, similar to established names in the industry.

SafetySit is a company focused on creating assistive therapeutic devices aimed at supporting disabled or recovering patients who struggle to maintain an upright sitting position due to insufficient core muscle strength. The company has developed a mobile backrest designed to aid clinicians in treating these patients, facilitating the early mobilization process essential for recovery. This innovative product reduces the need for clinicians to provide manual support, thereby enhancing the efficiency of therapy sessions and improving overall patient outcomes. By prioritizing user comfort and clinical effectiveness, SafetySit aims to advance rehabilitation practices and support the recovery journey for individuals with mobility challenges.

Galileo Innovations develops human performance-optimizing biotech gear and equipment for athletes, first responders, military members, and labor industry workers. Its proposed technology, KordoFan, augments users with actionable insights concerning environmental and biometric hazards in real-time to target heat injuries; through an array of biomimicry cooling designs, the device aids in speed, agility, mental clarity, muscle recovery, strength, and stamina during training/shifts.

NemoCare is developing the smartest and most comprehensive patient monitoring and management system. It is an innovative, continuous vital sign data acquisition, analysis and prediction engine that combines unobtrusive wireless wearable sensors and networks, analytical algorithms and big data to provide affordable continuous, high resolution monitoring for all newborns in hospital, and at home. We use design thinking principles to build life-saving technologies that will transform the way healthcare is delivered. Our current area of work is in newborn and maternal care.